YD Bio Limited Ordinary Shares
YDES | NASDAQ
$2.73
+$0.10 (+3.80%)
Sep 22, 2026, 1:44 PM ET · Market open
TTM Period Ending | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 |
|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.38M | -1.53M | -2.23M | -2.35M | -2.09M | -1.55M | -506.73K |
Interest Income | 326.75K | 463.16K | 598.18K | 643.75K | 508.21K | 337.22K | 167.64K |
Pretax Income | -2.99M | 16.34M | -2.3M | -2.05M | -4.22M | -21.33M | 676.42K |
Net Income | -2.97M | 16.34M | -2.3M | -2.03M | -4.22M | -21.32M | 692.04K |
Selling & General & Admin | 1.38M | 1.53M | 2.23M | 2.35M | 2.09M | 1.55M | 506.73K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.38M | 1.53M | 2.23M | 2.35M | 2.09M | 1.55M | 506.73K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.38M | 1.53M | 2.23M | 2.35M | 2.09M | 1.55M | 506.73K |
Income Tax Expense | -11.97K | -4.02K | n/a | -15.63K | -3.59K | -9.85K | -15.63K |
Shares Outstanding (Basic) | 3.41M | 3.42M | 4.03M | 4.03M | 4.22M | 4.3M | 4.3M |
Shares Outstanding (Diluted) | 3.41M | 3.42M | 4.03M | 4.03M | 4.22M | 4.3M | 4.3M |
EPS (Basic) | -0.99 | 3.71 | -0.43 | -0.37 | -0.91 | -4.96 | 0.16 |
EPS (Diluted) | -0.99 | 3.71 | -0.43 | -0.37 | -0.91 | -4.96 | 0.16 |
EBITDA | -2.99M | 16.34M | -2.3M | -2.05M | -4.22M | -21.33M | 676.42K |
EBIT | -2.99M | 16.34M | -2.3M | -2.05M | -4.22M | -21.33M | 676.42K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove YDES